LexDanaLexDanabeta
Inventor

Shaomeng Wang

Inventor
Saline, MI, US

Overview

60→
Patents
1999–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 60 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes24%
A61NElectrotherapy3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07KPeptides2%
C07CAcyclic or carbocyclic compounds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,829,488N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors202010,781,2085,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors202010,759,808Monofunctional intermediates for ligand-dependent target protein degradation202010,709,705Aminopyrimidines as ALK inhibitors202010,633,386BET protein degraders202010,500,194Covalent small molecule DCN1 inhibitors and therapeutic methods using the same201910,391,175BET bromodomain inhibitors and therapeutic methods using the same201910,307,4079H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors201910,253,0449H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors201910,221,174N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitors20199,783,539'Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors'20179,745,314'MDM2 inhibitors and therapeutic methods using the same'20179,675,697'BET bromodomain inhibitors and therapeutic methods using the same'20179,580,430'9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors'20179,403,856'Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same'20169,302,120'Spiro-oxindole MDM2 antagonists'20169,233,086'Inhibition of WDR5 interaction with its binding partners'20169,096,625'BCL-2/BCL-XL inhibitors and therapeutic methods using the same'20159,079,913'Spiro-oxindole MDM2 antagonists'20158,980,838'Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction'20158,901,117'Small molecule inhibitors of MDM2 and the uses thereof'20148,883,771'Bivalent inhibitors of IAP proteins and therapeutic methods using the same'20148,877,796'Spiro-oxindole MDM2 antagonists'20148,815,927'Bivalent diazo bicyclic Smac mimetics and the uses thereof'20148,742,121'Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein'20148,691,184'Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same'20148,680,132'Spiro-oxindole MDM2 antagonists'20148,664,212'Diazo bicyclic Smac mimetics and the uses thereof'20148,629,141'Spiro-oxindole MDM2 antagonists'20148,557,812'Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof'20138,518,984'Spiro-oxindole MDM2 antagonists'20138,486,981'Selective ligands for the dopamine 3 (D3) receptor and methods of using the same'20138,445,473'Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof'20138,283,368'Selective ligands for the dopamine 3 (D3) receptor and methods of using the same'20128,278,293'Diazo bicyclic Smac mimetics and the uses thereof'20128,222,288'Small molecule inhibitors of MDM2 and the uses thereof'20128,202,902'Bivalent SMAC mimetics and the uses thereof'20128,163,805'Small molecule antagonists of Bcl-2 family proteins'20128,088,931'Small molecule inhibitors of MDM2 and the uses thereof'20127,960,163'Matriptase, a serine protease and its applications'20117,960,372'Bivalent Smac mimetics and the uses thereof'20117,932,382'Conformationally constrained Smac mimetics and the uses thereof'20117,910,621'Small molecule antagonists of XIAP family proteins'20117,759,383'Small molecule inhibitors of MDM2 and the uses thereof'20107,737,174'Indole inhibitors of MDM2 and the uses thereof'20107,674,787'Conformationally constrained Smac mimetics and the uses thereof'20107,557,251'Production of gossypol co-crystals'20097,432,300'Gossypol co-crystals and the use thereof'20087,432,304'Small molecule antagonists of Bcl-2 family proteins'20087,427,689'ErbB-2 selective small molecule kinase inhibitors'20087,355,015'Matriptase, a serine protease and its applications'20087,354,928'Small molecule inhibitors targeted at Bcl-2'20087,342,046'Gossypol co-crystals and the use thereof'20087,268,115'Peptidomimetic modulators of cell adhesion'20076,703,382'Small molecule inhibitors targeted at Bcl-2'20046,677,377'Structure based discovery of inhibitors of matriptase for the treatment of cancer and other conditions'20046,284,784'Substituted 2-pyrrolidinone activators of PKC'20016,143,740'Heregulin antagonists and methods for their use'20005,962,504'Substituted 2-pyrrolidinone activators of PKC'19995,874,464'Conformationally constrained diacylglycerol analogues'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2008Based in Rockville, MD, US· patent location history
1999–2001Based in McLeane, VA, US· patent location history
2000Based in McLean, VA, US· patent location history
2004–2017Based in Saline, MI, US· patent location history
2008–2016Patents assigned to UNIV MICHIGAN (35)· patent assignee history
2012–2016Patents assigned to WANG SHAOMENG (18)· patent assignee history
2012–2014Patents assigned to NIKOLOVSKA-COLESKA ZANETA (7)· patent assignee history
2012–2014Patents assigned to QIU SU (5)· patent assignee history
2016–2020Patents assigned to UNIV MICHIGAN REGENTS (14)· patent assignee history
2017–2020Based in Superior Township, MI, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV MICHIGAN352008–2016
WANG SHAOMENGself182012–2016
UNIV MICHIGAN REGENTS142016–2020
NIKOLOVSKA-COLESKA ZANETA72012–2014
QIU SU52012–2014
Locations
LocationPatentsSpan
Saline, MI, US432004–2017
Superior Township, MI, US112017–2020
Rockville, Maryland, US31999–2008
McLeane, Virginia, US21999–2001
McLean, Virginia, US12000